No Data
No Data
The sales proportion of high-value consumables is increasing, and the microelectrophysiology sector is expected to turn a profit in 2024 after excluding non-recurring gains and losses.
① During the reporting period, the usage of TrueForce pressure catheters has grown rapidly both domestically and internationally since its launch, with a cumulative usage of over 5,000 cases, and commercialization achieved in more than 20 countries overseas; ② Regions with a high proportion of the company's overseas market revenue include the Middle East, Russia, Africa, and the EU area. The main reasons for growth are the opening of new countries, incremental coverage in existing regions, and the introduction of new products such as pressure catheters and magnetic positioning lung catheters.
Five consecutive rises! Hong Kong stocks are experiencing a strong rebound, Call Options for China Stocks ETF are being aggressively bought again, what is the outlook for the market?
China International Capital Corporation believes that from a long-term perspective, the Hong Kong stock market has not yet escaped the fluctuating pattern. To expand the market space, there are mainly two avenues: one is to rely on large-scale fiscal efforts to solve the current credit contraction issue faced by the economy; the other is the market pullback, creating better buying opportunities and greater rebound potential, referred to as 'opportunities arising from declines.'
**** had a phone call with the elected president of the USA, Trump.
**** congratulated Trump on being re-elected as President of the USA, pointing out that both sides highly value each other's interactions and hope that the China-US relationship has a good start in the new term of the USA President, wishing to promote greater progress in the China-US relationship from this new starting point.
The National Bureau of Statistics: In 2024, the total domestic product will be 134,908.4 billion yuan, with a growth of 5.0% compared to the previous year.
Looking at it by quarters, the gross domestic product grew by 5.3% year-on-year in the first quarter, 4.7% in the second quarter, 4.6% in the third quarter, and 5.4% in the fourth quarter. In terms of quarter-on-quarter, the gross domestic product grew by 1.6% in the fourth quarter.
Four bullish factors come together! Hong Kong stocks and A-shares surge collectively, with the Hang Seng TECH Index rising over 2%, and foreign capital attitude is showing a shift.
Against the backdrop of a significant decline in the Japanese stock market, the A-shares market has shown impressive performance in the Asia-Pacific region. In the early trading today, the number of stocks that rose exceeded 5,000, and all three major Indices went up. The A50 even surged sharply, and the Hong Kong stock market was also boosted.
An alternative "going abroad" for centralized procurement of pharmaceuticals and medical devices? The China-ASEAN regional centralized procurement platform for pharmaceuticals has been launched, and the industry anticipates the birth of the first Order.
① Today, the China-ASEAN pharmaceutical regional procurement platform officially launched, with representatives from Shenzhen Mindray Bio-Medical Electronics, United Imaging Healthcare, SIMCERE PHARMA, and other companies present; ② Although the specific implementation plan is yet to be clarified, the industry believes it is undoubtedly Bullish for domestic pharmaceutical companies; ③ The Southeast Asian pharmaceutical market is growing rapidly, but it relies heavily on imported drugs and medical devices.